JREZ:XETRA:XETRA-JPM Eurozone Research Enhanced Index Equity (ESG) UCITS ETF - EUR (acc) (EUR)

ETF | Others |

Last Closing

USD 32.895

Change

+0.49 (+1.51)%

Market Cap

N/A

Volume

301.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-04-26 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.34 (-0.66%)

USD 450.46B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.12 (-0.73%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.19 (-0.69%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.20 (-0.71%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.09 (-0.35%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

-0.34 (-0.23%)

USD 126.93B
8R80:XETRA Amundi Index Solutions - Amund..

-0.58 (-0.41%)

USD 104.09B
JARI:XETRA Amundi Index Solutions - Amund..

-0.27 (-0.61%)

USD 101.29B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.35 (-0.68%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

+3.56 (+0.71%)

USD 80.38B

ETFs Containing JREZ:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 9.18% 79% B- 77% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.18% 79% B- 76% C+
Trailing 12 Months  
Capital Gain 14.98% 66% D+ 68% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.98% 66% D+ 67% D+
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 4.21% 51% F 50% F
Dividend Return 4.21% 50% F 48% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 7.03% 74% C 80% B-
Risk Adjusted Return 59.86% 75% C 76% C+
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.